Chitosan nanoparticles as a potential drug delivery system for the ocular surface: Toxicity, uptake mechanism and in vivo tolerance

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 4, 2006, Pages 1416-1425

  De Salamanca, Amalia Enríquez ^a   Diebold, Yolanda ^a,b   Calonge, Margarita ^a   García Vazquez, Carmen ^a   Callejo, Sagrario ^b   Vila, Ana ^c,d   Alonso, Maria José ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d SL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; SODIUM AZIDE; BOVINE SERUM ALBUMIN; DRUG CARRIER; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE BOVINE SERUM ALBUMIN; MICROSPHERE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONFOCAL MICROSCOPY; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FLUOROMETRY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL COUNT; CELL CULTURE; CONJUNCTIVA; CORNEA; DRUG EFFECT; EPITHELIUM CELL; FEMALE; FLUOROPHOTOMETRY; HUMAN; METABOLISM; RABBIT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; CONJUNCTIVA; CORNEA; DRUG CARRIERS; EPITHELIAL CELLS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUOROPHOTOMETRY; HUMANS; MICROSCOPY, CONFOCAL; MICROSPHERES; RABBITS; SERUM ALBUMIN, BOVINE;

EID: 33645999705     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0495     Document Type: Article

References (31)

1. Harmia T, Speiser P, Kreuter J. A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles. J Microencapsulation. 1986;3:3-12.
2. Losa C, Calvo P, Vila-Jato JL, Alonso MJ. Improvement of ocular penetration of a amikacin sulphate by association to poly-(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol. 1991;43:548-552.
3. Losa C, Marchal-Heussler L, Orallo F, Vila-Jato JL, Alonso MJ. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharmacol Res. 1993;10: 80-87.
4. Calvo P, Thomas C, Alonso MJ, Vila-Jato JL, Robinson JR. Study of the mechanism of interaction of poly-e-caprolactone nanocapsules with the cornea by confocal laser scanning microscopy. Int J Pharmacol. 1994;103:283-291.
5. Calvo P, Sánchez A, Martínez J, et al. Polyester nanocapsules as new topical ocular delivery systems for cyclosporine A. Pharmacol Res. 1996;13:311-315.
6. Alonso MJ, Sánchez A. Biodegradable nanoparticles as new transmucosal drug carriers. In: Sönke Svenson, ed. Carrier-Based Drug Delivery. Washington DC: ACS Symposium Series; 2004:283-295.
7. Hirano S, Seino H, Akiyama I, Nonaka I. Chitosan: a biocompatible material for oral and intravenous administration. In: Gebelein CG, Dunn RL, eds. Progress in Biomedical Polymers. New York: Plenum Press; 1990:283-289.
8. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm. 1992;78:43-48.
9. Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 1998;24:979-993.
10. Alonso MJ, Sánchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol. 2003;55:1451-1463.
11. Fernández-Urrusuno R, Calvo P, Remuñan-López C, Vila-Jato JL, Alonso MJ. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharmacol Res. 1999;16:1576-1581.
12. Vila A, Sánchez A, Janes K, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm. 2004;57:123-131.
13. Behrens I, Vila-Pena A, Alonso MJ, Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharmacol Res. 2002;19:1185-1193.
14. de Campos A, Sánchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporine A. Int J Pharm. 2001; 224:159-168.
15. de Campos AM, Diebold Y, Carvalho EL, Sánchez A, Alonso MJ. Chitosan Nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate and cellular toxicity. Pharmacol Res. 2004;21:803-810.
16. de Campos AM, Sánchez A, Gref R, Calvo P, Alonso MJ. The effect of a PEG coating vs a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci. 2003; 20:73-81.
17. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polymer Sci. 1997;63:125-132.
18. Alonso MJ. Nanoparticulate drug carrier technology. In: Cohen S, Bernstein H, eds. Microparticulate Systems for the Delivery of Proteins and Vaccines. New York: Marcel Dekker; 1996;203-242.
19. Diebold Y, Calonge M, Enríquez de Salamanca A, et al. Characterization of a spontaneously inmortalizated cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 2003; 44:4263-4274.
20. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm. 2005;288:369-376.
21. Russell-Jones GJ, Arthur L, Walker H. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. Int J Pharm. 1999;179: 247-255.
22. Organization for Economic Co-operation and Development. Test guideline 405: Acute Eye Irritation/Corrosion; 2002. Available online at http://www.oecd.org.
23. Calonge M, Diebold Y, Sáez V, et al. Impression cytology of the ocular surface: a review. Exp Eye Res. 2004;78:457-472.
24. Nelson JD. Impression cytology. Cornea. 1988;7:71-81.
25. Jani P, Halbert GW, Langridge J, Florence AT. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol. 1990;42:821-826.
26. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharmacol Res. 1996;13:1838-1845.
27. Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. Design of biodegradable particles for protein delivery. J Control Rel. 2002;78:15-24.
28. Lee VHL. Corneal and conjunctival primary culture models for drug delivery and disposition (abstract). AAPS Pharm Sci Suppl. 2000;4:2.
29. Argüeso P, Gipson IK. Epithelial mucins of the ocular surface: structure, biosynthesis and function. Exp Eye Res. 2001;73:281-289.
30. Kawazu K, Yamada K, Nakamura M, Ota A. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. Invest Ophthalmol Vis Sci. 1999;40:1738-1744.
31. Freeberg FE, Nixon GA, Reer PJ, et al. Human and rabbit eye responses to chemical insult. Fund Appl Toxicol. 1986;7:626-634.